BIOGEN INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOGEN INC, and what generic alternatives to BIOGEN INC drugs are available?
BIOGEN INC has three approved drugs.
There are seventeen US patents protecting BIOGEN INC drugs.
There are two hundred and eighteen patent family members on BIOGEN INC drugs in forty-two countries and forty-six supplementary protection certificates in thirteen countries.
Summary for BIOGEN INC
International Patents: | 218 |
US Patents: | 17 |
Tradenames: | 3 |
Ingredients: | 3 |
NDAs: | 3 |
PTAB Cases with BIOGEN INC as patent owner: | See PTAB cases with BIOGEN INC as patent owner |
Drugs and US Patents for BIOGEN INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-002 | Mar 27, 2013 | AB | RX | Yes | Yes | 11,129,806 | ⤷ Sign Up | ⤷ Sign Up | |||
Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-002 | Mar 27, 2013 | AB | RX | Yes | Yes | 11,007,167 | ⤷ Sign Up | ⤷ Sign Up | |||
Biogen Inc | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-001 | Oct 31, 2023 | RX | Yes | No | 10,172,871 | ⤷ Sign Up | ⤷ Sign Up | ||||
Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | AB | RX | Yes | No | 10,555,993 | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BIOGEN INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | 8,759,393 | ⤷ Sign Up |
Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-002 | Mar 27, 2013 | 8,759,393 | ⤷ Sign Up |
Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-002 | Mar 27, 2013 | 7,320,999 | ⤷ Sign Up |
Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | 6,509,376 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BIOGEN INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-releaseCapsules | 120 mg and 240 mg | ➤ Subscribe | 2017-03-27 |
International Patents for BIOGEN INC Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Finland | 2629097 | ⤷ Sign Up |
Mexico | 2017006473 | ⤷ Sign Up |
Serbia | 58297 | ⤷ Sign Up |
China | 107106530 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BIOGEN INC Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0526708 | SPC/GB02/030 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: BOSENTAN 4-(1,1-DIMETHYLETHYL)-N-(6-(2-HYDROXYETHOXY)-5-(2-METHOXYPHENOXY)-2(PYRIMIDIN-2-YL)PYRIMIDIN-4-YL)BENZENESULFONAMIDE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |
1761528 | CA 2014 00055 | Denmark | ⤷ Sign Up | PRODUCT NAME: TRAMETINIB, EVENTUELT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT, HYDRAT ELLER SOLVAT DERAF, HERUNDER TRAMETINIBDIMETHYLSULFOXID; REG. NO/DATE: EU/1/14/931/01-06 20140630 |
2137537 | 132014902274513 | Italy | ⤷ Sign Up | PRODUCT NAME: DIMETILFUMARATO(TECFIDERA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/13/837/001-002, 20140203 |
1131065 | CA 2014 00036 | Denmark | ⤷ Sign Up | PRODUCT NAME: DIMETHYL FUMARAT (DIMETHYLFUMARAT); REG. NO/DATE: EU/1/13/837/001-002 20140130 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.